In Vivo Targeting of Escherichia coli with Vancomycin-Arginine
Sign Up to like & getrecommendations! Published in 2021 at "Antimicrobial Agents and Chemotherapy"
DOI: 10.1128/aac.02416-20
Abstract: The ability of vancomycin-arginine (V-r) to extend the spectrum of activity of glycopeptides to Gram-negative bacteria was investigated. Its MIC toward Escherichia coli, including β-lactamase expressing Ambler classes A, B, and D, was 8 to… read more here.
Keywords: coli including; targeting escherichia; vancomycin arginine; escherichia coli ... See more keywords